Combining DNA Damaging Agents and Checkpoint 1 Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-5968|4|5|435-438

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.4, Iss.5, 2004-09, pp. : 435-438

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pyrrolocarbazoles as Checkpoint 1 Kinase Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 6, 2008-08 ,pp. : 577-597

Bentham Science Publishers

Access to resources Recommend Favorite

Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary (Review)

By      

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 571-576

Spandidos Publications

Access to resources Recommend Favorite

Insights into Apoptosis Mechanisms Induced by DNA-Damaging Agents in Burkitt's Lymphoma Cells

By Simoes Magluta Eliane   da Cunha Vasconcelos Flavia   Maia Raquel Ciuvalschi   Klumb Claudete Esteves  

Cancer Investigation, Vol. 27, Iss. 8, 2009-10 ,pp. : 830-835

Informa Healthcare

Access to resources Recommend Favorite

Tumor Cell Resistance to DNA-Damaging Agents: From Apoptosis to Neiosis

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 5, 2004-09 ,pp. : 461-463

Bentham Science Publishers

Access to resources Recommend Favorite

Poly ADP-ribosylation in two L5178Y murine lymphoma sublines differentially sensitive to DNA-damaging agents

By Kleczkowska H. E.   Malanga M.   Szumiel I.   Althaus F. R.  

International Journal of Radiation Biology, Vol. 78, Iss. 6, 2002-06 ,pp. : 527-534

Informa Healthcare

Access to resources Recommend Favorite